广泛而渐进的脑缩是线粒体疾病患者的常见特征
Nora Mickelsson1,2, Jussi Hirvonen3,4, Mika H Martikainen5,6,7,8,9
1Clinical Neurosciences, Department of Clinical Medicine, University of Turku, Turku, Finland.
Journal of neurology
|September 23, 2025
概括
大脑缩在线粒体疾病中很常见,特别是在后部区域. 这种神经退行随着时间的推移而进展,特别是在经历中风类发作 (SLEs) 的患者中,突出了神经保护治疗的必要性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 放射学 放射学是一门学科.
背景情况:
- 主要线粒体疾病是遗传性疾病,通常会影响中枢神经系统.
- 虽然脑成像发现已知,但关于体积变化和临床相关性的纵向数据有限.
研究的目的:
- 为了研究线粒体疾病中的纵向体积大脑异常.
- 评估大脑缩的进展及其与诸如中风类发作 (SLEs) 等临床特征的关联.
主要方法:
- 对36名经遗传确认的线粒体疾病患者进行了回顾性观察性研究.
- 使用cNeuro®对73个脑部MRI扫描进行分析,以量化叶状和区域皮质缩.
- 研究缩和临床特征 (SLEs,性别,遗传亚型) 之间的关联.
主要成果:
- 所有患者都表现出脑缩,最突出的是叶和叶.
- 患有SLE的患者在叶,叶和叶中显著增加了缩.
- 随访成像显示了SLEs患者的渐进性缩,特别是在叶.
结论:
- 大脑缩是线粒体疾病的常见,渐进的特征,影响大脑后部区域.
- 在SLE患者中,缩进展更明显,表明神经退行.
- 这些发现强调了开发神经保护疗法治疗线粒体疾病的必要性.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Cross-bridge Cycle
121.9K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
121.9K
ATP Synthase: Mechanism
16.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.5K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K


